Sofwave To Participate In Upcoming November Investor Conferences

(MENAFN- GlobeNewsWire - Nasdaq) SAN CLEMENTE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the following investor conferences:

Stifel 2026 Healthcare Conference
Presentation Format: Corporate overview
Presentation Date: Tuesday, November 10, 2026
Presentation Time: 4:40 p.m. ET
Webcast: Click Here

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Presentation Format: Corporate overview
Presentation Date: Wednesday, November 11, 2026
Presentation Time: 12:30 p.m. ET
Webcast: Click Here

About Sofwave Medical Ltd.
Sofwave Medical Ltd. (TASE: SOFW) is a global regenerative aesthetics company advancing non-invasive technologies for skin and body. Its proprietary SUPERBTM (Synchronous Ultrasound Parallel Beam) technology delivers controlled ultrasound energy to the mid-dermis to stimulate the body's natural regenerative response and is FDA-cleared for the treatment of facial lines and wrinkles, lifting the eyebrow and lax submental and neck tissue, improving the appearance of skin laxity on the upper arms, short-term improvement in the appearance of cellulite, and treatment of acne scars.

Sofwave's portfolio also includes Pure ImpactTM, which utilizes electrical muscle stimulation (EMS) technology for muscle strengthening, toning and firming. Together, Sofwave's technologies provide physicians with clinically supported, non-invasive solutions for the evolving needs of aesthetic patients worldwide.

Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
...

MENAFN28102026004107003653ID1111878718